Privatlivspræferencer
Inderes bruger cookies for at give en bedre brugeroplevelse og en personlig service. Ved at give samtykke til brugen af cookies kan vi udvikle en endnu bedre service og vil kunne levere indhold, der er interessant for dig.
  • Forum
  • Aktiemarkeder
    • MarkederRealtidskurser, indekser og markedsudvikling
    • BørskalenderKommende resultater, noteringer og virksomhedsbegivenheder
    • UdbyttekalenderKommende og tidligere udbytter
  • Selskaber
    • SelskaberGennemse og filtrer den fulde liste over børsnoterede selskaber
    • OpdagInspiration til din næste investering
    • BørsnoteringerNye noteringer og kommende børsintroduktioner
    • Invitationer til generalforsamlingerDatoer for generalforsamlinger og aktionærinformation
  • Aktieanalyse
    • ResearchEkspertaktieanalyse og anbefalinger
    • ArtiklerNyheder, indsigter og markedskommentarer
    • inderesTVVideocenter for aktieanalyse, forskning og ekspertkommentarer
    • TransskriptionerFuldstændige udskrifter af resultatopkald og investormøder
    • AktieoversigtSammenlign nøgletal og udvikling på tværs af flere aktier
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer

Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.

Generic: Volumes continue to grow - ABG

GENIEksterne analyser20.08.2026, 07.53

Dette er en ekstern analyse og afspejler ikke nødvendigvis vores perspektiv eller værdier

Download analyse (PDF)
* Volumes strong, sales up 10% y-o-y
* Adj. EBIT growth of 8% y-o-y, margin of 21%
* DOCS now penetrated >30% of municipalities

Q2'26 details

Generic Sweden reported Q2'26 sales of 48.7m, in line with our expectations (0% vs ABGSCe 48.7m), mostly driven by higher volumes in the SMS business (messaging segment), where we started to see a bottoming out already in Q1. Messaging solutions grew 10.7% y-o-y, and this could potentially be an end to the customer cost cautiousness that has held back the segment. The gross margin came in at 44%, in line with what we thought. Reported EBIT was held back by roughly SEK 1m from the settlement of holiday pay liabilities for older holiday days. Adjusting for this, adj. EBIT was SEK 10.3m, up 8% y-o-y and 10% above our SEK 9.4m.

Thoughts

The DOCS product continues to be a success story, and the penetration rate keeps climbing, with around 31% of Swedish municipalities now having the product. The share of wallet is unknown, but breaking into the public sector often takes time, as municipalities tend to sit on long frameworks. We therefore see this penetration rate as very positive for Generic. Growth in the segment was nevertheless lower this quarter at 11%, partly because much of the focus went to one of Sweden's larger municipalities, which went live later than initially planned.

Valuation

The company is valued at 10-9x adj. EBIT on our unrevised numbers for '26e-'27e, around 55% below its peers. Generic continues to operate with 21 employees (22 in Q2'25), making it one of the highest sales-per-employee companies in the Swedish tech sector.